GSTM1 and anemia: Lee and colleagues (7) have demonstrated that moderate-severe (Hb < 10) or mild (Hb < 10 < 12) anemia is associated with increased one-year mortality, hospital length of stay, post-PCI cardiac enzymes, and 30-day MACE.